Article Text

Download PDFPDF
FRAX tool underestimates the risk of osteoporotic fractures in mental disorders
  1. Rajender R Aparasu,
  2. Sanika Rege
  1. Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas, USA
  1. Correspondence to Dr Rajender R Aparasu; rraparasu{at}

Statistics from

COMMENTARY ON: Bolton JM, Morin SN, Majumdar SR, et al. Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiatry 2017;74:641–8.

What is already known on this topic

Selected mental disorders and specific psychotropic medications are associated with increased risk of fracture and osteoporosis and adversely impact bone mineral density (BMD).1 2 Fractures are associated with high mortality and morbidity rates and increased disability burden and socioeconomic costs.3 FRAX, a fracture risk assessment tool, assesses the 10-year probability of major osteoporotic fractures (MOF) based on eight clinical risk factors and BMD.4 5 It was developed and calibrated based on population-based cohorts in several regions throughout the world. Although FRAX is included in numerous osteoporosis guidelines, there is a need to strengthen the tool by incorporating additional clinical risk factors and evaluating its utility in specific subpopulations. Therefore, it is important …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.